Jonathan Curtain, the new CFO of Ergomed PLC (AIM:ERGO, ETR:2EM), discussed his background and the company's growth prospects in an interview with Proactive London.
The specialist services provider to the pharmaceutical industry focuses on growth areas like rare diseases and oncology.
Curtain brings extensive experience in finance and investor relations from his previous role as Senior Vice President of Finance at NASDAQ-listed CRO, Icon PLC.
With strong financial results in 2022, showing revenue growth of 23% and an increased order book, Curtain expressed confidence in Ergomed's ability to deliver and execute projects, and highlighted their positive outlook for mergers and acquisitions to further strengthen their services.
Despite industry headwinds, the company remains optimistic about its future prospects.